The unified call for affordable diabetes technology masks a deeper regulatory battle. Who truly benefits from this 'access' push?
VCU Health's move on Hospital-at-Home and RPM governance isn't about patient care; it's a power play defining the future of digital health.
The FDA's Digital Health Center of Excellence signals a massive shift. Unpacking the true cost of centralized **digital health regulation** and **FDA oversight** in personalized **health tech**.
The ABN/Nyxoah cleanroom deal isn't about modularity; it's a strategic pivot that could shatter established supply chains in advanced medical device manufacturing.
The FDA's new TEMPO digital health pilot signals a massive shift in medical device oversight. Who really benefits from this accelerated regulatory path?
The FDA's new digital health services pilot, lauded by the AHA, signals a massive shift in medical liability. Discover who really benefits from this regulatory experiment.